Hydra International Limited – Trademark Portfolio
Entity Type: 99
Hydra International Limited holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include HYDRA. The owner is based in Milton Keynes.
8, Carters Lane, Kiln Farm
Milton Keynes MK11 3ER , GB
Showing of trademarks Trademarks
Trademark Classifications
Hydra International Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Hydra International Limited have?
Hydra International Limited has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Hydra International Limited file in?
Hydra International Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Hydra International Limited's most well-known trademarks?
Hydra International Limited's registered trademark portfolio includes well-known marks such as HYDRA. These are among 1 currently registered trademark in the portfolio.
What is Hydra International Limited's trademark registration success rate?
Hydra International Limited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.